Simplex Trading’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-27
Closed 9563
2024
Q2
$0 Sell
27
-60
-69% -$716 ﹤0.01% 9806
2024
Q1
$1K Buy
+87
New +$1.74K ﹤0.01% 8649
2023
Q3
Sell
-94
Closed -$4.05K 9803
2023
Q2
$7K Buy
94
+33
+54% +$2.67K ﹤0.01% 7722
2023
Q1
$5K Sell
61
-259
-81% -$24.7K ﹤0.01% 8083
2022
Q4
$31K Buy
320
+206
+181% +$29.9K ﹤0.01% 6437
2022
Q3
$29K Sell
114
-24
-17% -$6.97K ﹤0.01% 7121
2022
Q2
$25K Sell
138
-360
-72% -$34.4K ﹤0.01% 7355
2022
Q1
$48K Buy
498
+281
+129% +$36.1K ﹤0.01% 7194
2021
Q4
$35K Sell
217
-378
-64% -$83.1K ﹤0.01% 7706
2021
Q3
$243K Hold
595
﹤0.01% 5289
2021
Q2
$235K Buy
595
+40
+7% +$18.7K ﹤0.01% 5421
2021
Q1
$299K Buy
555
+281
+103% +$175K ﹤0.01% 4150
2020
Q4
$103K Sell
274
-29
-10% -$11.5K ﹤0.01% 5418
2020
Q3
$114K Sell
303
-220
-42% -$97.2K ﹤0.01% 4768
2020
Q2
$257K Buy
523
+214
+69% +$95.4K ﹤0.01% 3712
2020
Q1
$113K Buy
309
+45
+17% +$23.3K ﹤0.01% 4237
2019
Q4
$186K Buy
264
+202
+326% +$139K ﹤0.01% 3851
2019
Q3
$40K Sell
62
-277
-82% -$220K ﹤0.01% 5238
2019
Q2
$296K Buy
339
+67
+25% +$46.1K ﹤0.01% 3085
2019
Q1
$157K Buy
272
+40
+17% +$16.7K ﹤0.01% 3865
2018
Q4
$65K Sell
232
-193
-45% -$76.3K ﹤0.01% 4280
2018
Q3
$203K Sell
425
-4
-0.9% -$1.72K ﹤0.01% 3630
2018
Q2
$194K Sell
429
-153
-26% -$97K ﹤0.01% 3527
2018
Q1
$341K Buy
582
+421
+261% +$262K 0.02% 915
2017
Q4
$99K Sell
161
-49
-23% -$35.2K ﹤0.01% 1808
2017
Q3
$193K Buy
+210
New +$187K 0.01% 1209
2017
Q2
Sell
-116
Closed -$114K 6777
2017
Q1
$109K Sell
116
-85
-42% -$79.1K ﹤0.01% 1667
2016
Q4
$161K Buy
201
+103
+105% +$92.8K 0.01% 1200
2016
Q3
$83K Sell
98
-240
-71% -$193K 0.01% 1685
2016
Q2
$278K Buy
338
+236
+231% +$257K 0.02% 812
2016
Q1
$113K Sell
102
-258
-72% -$264K 0.01% 1253
2015
Q4
$449K Buy
360
+123
+52% +$203K 0.04% 472
2015
Q3
$320K Buy
237
+199
+524% +$328K 0.02% 656
2015
Q2
$68K Buy
+38
New +$59K 0.01% 1452

Other funds holding TCRT

Simplex Trading's TCRT Position: Q3 2024 in Review

Simplex Trading sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 27 shares.

Simplex Trading first reported a position in TCRT in Q2 2015 and held it in 34 quarters. The position peaked at $449K in Q4 2015. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

  • Simplex Trading reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 27 Alaunos Therapeutics shares in Q3 2024.
  • Simplex Trading first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 34 quarters.
  • Simplex Trading's Alaunos Therapeutics position peaked at $449K in Q4 2015.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.